Want to see IN:ANURAS full AI Analyst Report?
Top Page
Anupam Rasayan India Ltd.
(ANURAS)
Select Model
Select Model
Rating:53Neutral
Price Target:
₹1,274.00
▲(1.10% Upside)
Action:Reiterated
Date:08/25/26
The score is held back primarily by weak cash generation (recurring negative free cash flow) and a high valuation (P/E ~81.6). These risks are partially offset by the FY2026 revenue rebound and still-healthy operating margins, while technical indicators are mixed with modest momentum but limited longer-term trend support.
Positive Factors
Revenue Recovery
The FY2026 rebound indicates demand recovery after two weaker years. Sustained growth in contract-led specialty chemicals would improve utilization and spread fixed costs, supporting earnings resilience if customer volumes continue to recover.
Negative Factors
Weak Free Cash Flow
Persistent negative free cash flow limits internally generated funding and may increase reliance on debt or external capital. If working-capital needs and reinvestment remain high, earnings growth may not translate into stronger financial flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Recovery
The FY2026 rebound indicates demand recovery after two weaker years. Sustained growth in contract-led specialty chemicals would improve utilization and spread fixed costs, supporting earnings resilience if customer volumes continue to recover.
Read all positive factors
Anupam Rasayan India Ltd. (ANURAS) vs. iShares MSCI India ETF (INDA)
Market Cap
₹139.76B
Dividend Yield0.12%
Average Volume (3M)3.84K
Price to Earnings (P/E)80.0
Beta (1Y)0.59
Revenue Growth51.77%
EPS Growth36.90%
CountryIN
Employees2,606
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)15.38
Shares Outstanding113,849,840
10 Day Avg. Volume4,072
30 Day Avg. Volume3,840
Financial Highlights & Ratios
PEG Ratio1.05
Price to Book (P/B)4.16
Price to Sales (P/S)5.87
P/FCF Ratio-38.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)21.23
Revenue Forecast (FY)₹27.26B
Anupam Rasayan India Ltd. Business Overview & Revenue Model
Company Description
Anupam Rasayan India Ltd., established in Surat, India, in 1984, specializes in the custom synthesis and production of specialty chemicals. The company manufactures a diverse range of life science-oriented chemicals, including intermediates and ac...
How the Company Makes Money
ANURAS primarily makes money by manufacturing and selling specialty chemicals, largely through a contract/relationship-driven model rather than commodity bulk chemicals. Key revenue streams include: (1) Custom synthesis / contract manufacturing: T...
Anupam Rasayan India Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
68
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.35B | 23.65B | 14.42B | 14.80B | 16.02B | 10.74B |
| Gross Profit | 9.27B | 8.16B | 8.22B | 8.51B | 8.85B | 7.02B |
| EBITDA | 5.76B | 5.43B | 4.00B | 3.82B | 4.29B | 3.03B |
| Net Income | 1.75B | 1.70B | 933.49M | 1.29B | 1.81B | 1.52B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 80.13B | 52.69B | 46.02B | 37.78B | 28.91B |
| Cash, Cash Equivalents and Short-Term Investments | 4.11B | 4.11B | 1.35B | 3.48B | 6.67B | 618.77M |
| Total Debt | 0.00 | 18.67B | 13.73B | 10.70B | 8.22B | 8.36B |
| Total Liabilities | -46.30B | 33.83B | 21.87B | 16.71B | 12.70B | 11.64B |
| Stockholders Equity | 46.30B | 33.34B | 28.50B | 27.61B | 23.73B | 17.27B |
Cash Flow | ||||||
| Free Cash Flow | 3.28B | -3.57B | -4.40B | -6.57B | 713.03M | -3.18B |
| Operating Cash Flow | 5.35B | 1.99B | -301.25M | 590.32M | 2.92B | -1.71B |
| Investing Cash Flow | -2.53B | -8.21B | -3.30B | -3.92B | -5.23B | -4.12B |
| Financing Cash Flow | 182.51M | 7.57B | 2.23B | 3.95B | 3.71B | 3.84B |
Anupam Rasayan India Ltd. Technical Analysis
Negative
1260.10
Price Trends
1240.10
Negative
1280.98
Negative
1277.26
Negative
Market Momentum
0.61
Positive
43.24
Neutral
14.69
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ANURAS, the sentiment is Negative. The current price of 1260.1 is above the 20-day moving average (MA) of 1238.41, above the 50-day MA of 1240.10, and below the 200-day MA of 1277.26, indicating a bearish trend. The MACD of 0.61 indicates Positive momentum. The RSI at 43.24 is Neutral, neither overbought nor oversold. The STOCH value of 14.69 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ANURAS.
Anupam Rasayan India Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹183.06B | 23.53 | ― | 0.47% | 15.75% | 59.22% | |
68 Neutral | ₹99.37B | 43.61 | ― | 0.52% | 5.11% | 20.64% | |
59 Neutral | ₹214.04B | 92.31 | ― | ― | 33.79% | 34.24% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ₹139.76B | 80.05 | ― | 0.12% | 51.77% | 36.90% | |
53 Neutral | ₹107.12B | 34.11 | ― | 0.75% | 10.96% | 11.16% | |
45 Neutral | ₹180.29B | 34.41 | ― | 0.20% | 27.05% | 123.98% |
* General Sector Average
IN:ANURAS
Anupam Rasayan India Ltd.
1,231.50
137.65
12.58%
IN:AARTIIND
AARTI Industries Ltd
504.45
112.65
28.75%
IN:AETHER
Aether Industries Ltd.
1,642.70
906.25
123.06%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,922.15
-114.46
-5.62%
IN:ATUL
Atul Limited
6,345.45
-43.86
-0.69%
IN:JUBLINGREA
Jubilant Ingrevia Ltd.
667.25
-41.13
-5.81%
Anupam Rasayan India Ltd. Corporate Events
Anupam Rasayan Files Q1 FY27 Results, Appoints New COO
Aug 14, 2026
Anupam Rasayan India Ltd. reported its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following a board meeting held on August 14. The results have undergone a limited review by the statutory auditor, ...
Anupam Rasayan Elevates Ravi Desai to Chief Operating Officer
Aug 14, 2026
Anupam Rasayan India Ltd. has appointed Ravi Desai as Chief Operating Officer, effective August 14, 2026, following approval by the board based on the Nomination and Remuneration Committee’s recommendation. Desai, who has been with the compa...
Anupam Rasayan Confirms Full Demat Shareholding, SEBI Rule 74(5) Not Applicable
Jul 7, 2026
Anupam Rasayan India Ltd. has reported that all its equity shares are held in dematerialized form, with no physical share certificates in circulation among its investors. The company’s registrar and transfer agent, MUFG Intime India Private ...
Anupam Rasayan Credit Rating Kept at IND AA- with Negative Watch by Ind-Ra
Jun 3, 2026
Anupam Rasayan India Ltd. has announced that India Ratings and Research has updated its credit ratings, maintaining an issuer rating of IND AA- with a Rating Watch with Negative Implications. Bank loan facilities, both existing and newly rated, as...
Anupam Rasayan Raises ₹160 Crore via Secured NCD Issue to Aditya Birla Capital
May 26, 2026
Anupam Rasayan India Ltd. has issued and allotted 16,000 secured, rated, unlisted, redeemable non-convertible debentures of ₹1,00,000 each, raising a total of ₹160 crore in a single tranche via private placement to Aditya Birla Capital...
Anupam Rasayan Publishes FY26 Audited Results in Newspapers and Online
May 25, 2026
Anupam Rasayan India Ltd. has notified the stock exchanges that it has published newspaper advertisements of its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The results have been p...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.